Zentalis Pharmaceuticals (ZNTL)
Develops azenosertib for biomarker-selected platinum-resistant ovarian cancer.
$2.80
vs last close−0.28 (−9.25%)
Something off on this page? Send us feedback.
Next report
Nov 10, 26
estimated · in 48 days
EPS estimate
−$0.58
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.66−$0.67−$0.37−$0.37−$0.49−$0.50−$0.59Pending
Estimate−$0.75−$0.67−$0.56−$0.49−$0.41−$0.49−$0.49−$0.58
Surprise+12.0%0.0%+33.9%+24.5%−19.5%−2.0%−20.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$26.9M——————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.54 | — | — |
| Sep 2028 | −$0.54 | — | — |
| Jun 2028 | −$0.54 | — | — |
| Mar 2028 | −$0.53 | — | — |
| Dec 2027 | −$0.51 | — | — |
| Sep 2027 | −$0.51 | — | — |
| Jun 2027 | −$0.52 | — | — |
| Mar 2027 | −$0.53 | — | — |
| Dec 2026 | −$0.54 | — | — |
| Nov 2026 | −$0.58 | — | — |
| Aug 2026 | −$0.49 | −$0.59 | −20.4% |
| May 2026 | −$0.49 | −$0.50 | −2.0% |
| Mar 2026 | −$0.41 | −$0.49 | −19.5% |
| Nov 2025 | −$0.49 | −$0.37 | +24.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.54 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.54 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.54 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.53 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.51 | — | — | $7.2M | — | — | — |
| Sep 2027 | −$0.51 | — | — | $2.6M | — | — | — |
| Jun 2027 | −$0.52 | — | — | $1.2M | — | — | — |
| Mar 2027 | −$0.53 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.54 | — | — | $0 | — | — | — |
| Nov 10, 2026 | −$0.58 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.49 | −$0.59 | −20.4% | — | — | — | −15.6% |
| May 12, 2026 | −$0.49 | −$0.50 | −2.0% | — | — | — | +3.4% |
| Mar 26, 2026 | −$0.41 | −$0.49 | −19.5% | — | — | — | +4.7% |
| Nov 10, 2025 | −$0.49 | −$0.37 | +24.5% | — | — | — | +3.1% |
| Aug 6, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Apr 6, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |